financetom
Business
financetom
/
Business
/
BRIEF-Blank Check Company Drugs Made In America Acquisition II Corp Sees IPO Of $500 Million - SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Blank Check Company Drugs Made In America Acquisition II Corp Sees IPO Of $500 Million - SEC Filing
Jul 21, 2025 3:19 AM

July 21 (Reuters) -

* BLANK CHECK COMPANY DRUGS MADE IN AMERICA ACQUISITION II

CORP

SEES IPO OF $500 MILLION - SEC FILING

* DRUGS MADE IN AMERICA ACQUISITION II CORP INTENDS TO LIST

UNITS

ON THE NASDAQ UNDER SYMBOL "DMIIU"- SEC FILING

* DRUGS MADE IN AMERICA ACQUISITION II CORP: CANTOR IS

UNDERWRITER

TO IPO - SEC FILING

Source text:

Further company coverage: [ ]

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Expand Energy ousts CFO Mohit Singh
Expand Energy ousts CFO Mohit Singh
Aug 14, 2025
Aug 14 (Reuters) - Expand Energy ( EXE ) said on Thursday Mohit Singh, its chief financial officer since 2021, has left the natural gas producer, effective August 13. Singh departed due to a termination without cause and will pursue other interests, the company said. Expand Energy ( EXE ) and Singh did not immediately respond to requests for comment....
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Invivyd Gets FDA Guidance on Rapid Path to Potential BLA Approval for COVID-19 Antibody
Invivyd Gets FDA Guidance on Rapid Path to Potential BLA Approval for COVID-19 Antibody
Aug 14, 2025
06:04 PM EDT, 08/14/2025 (MT Newswires) -- Invivyd ( IVVD ) said late Thursday it received advice from the US Food and Drug Administration on a rapid pathway to potential biologics license application approval for VYD2311 for protection against COVID-19. The alignment follows a Type C meeting, where the FDA advised that a single, phase 2/3 trial evaluating the candidate...
Brazil's BRF posts Q2 net profit of $136 million, dodging bird flu trade disruptions
Brazil's BRF posts Q2 net profit of $136 million, dodging bird flu trade disruptions
Aug 14, 2025
SAO PAULO (Reuters) -Brazilian food processor BRF, the world's largest chicken exporter, said it earned 735 million reais ($136 million) in the second quarter despite trade disruptions caused by an outbreak of bird flu in May, which triggered trade bans. The company, which also processes pork and prepared food products, said earnings before interest, tax, depreciation and amortization, a measure...
Copyright 2023-2026 - www.financetom.com All Rights Reserved